We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

donderdag 17 augustus 2017

Cancer Gene Therapy - Table of Contents alert Volume 24 Issue 7

If you are unable to see the message below, click here to view.
Cancer Gene Therapy

Advertisement
Cell and gene therapies offer tremendous hope, yet immense complexities. Innovators must overcome unprecedented challenges to bring these products to patients...but where do they start? In our newest white paper, AmerisourceBergen offers more than 70 pages of insights on what it takes to design and execute an effective commercialization strategy when the patient is in the supply chain.

Read more

TABLE OF CONTENTS

Volume 24, Issue 7 (July 2017)

In this issue
Original Articles

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Original Articles

Top

Phase I/II clinical trial to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E in castration-resistant prostate cancer patients OPEN

K Fujita, Y Nakai, A Kawashima, T Ujike, A Nagahara, T Nakajima, T Inoue, C M Lee, M Uemura, Y Miyagawa, Y Kaneda and N Nonomura

Cancer Gene Ther 2017 24: 277-281; advance online publication, May 12, 2017; 10.1038/cgt.2017.15

Abstract | Full Text

Research on miRNA-195 and target gene CDK6 in oral verrucous carcinoma

Z Deng, Y Wang, X Fang, F Yan, H Pan, L Gu, C Xie, Y Li, Y Hu, Y Cao and Z Tang

Cancer Gene Ther 2017 24: 282-288; advance online publication, June 16, 2017; 10.1038/cgt.2017.18

Abstract | Full Text

Combination of p53-DC vaccine and rAd-p53 gene therapy induced CTLs cytotoxic against p53-deleted human prostate cancer cells in vitro

H Saito, K Kitagawa, T Yoneda, Y Fukui, M Fujsawa, D Bautista and T Shirakawa

Cancer Gene Ther 2017 24: 289-296; advance online publication, June 16, 2017; 10.1038/cgt.2017.21

Abstract | Full Text

An analysis of the polymorphisms of the GLUT1 gene in urothelial cell carcinomas of the bladder and its correlation with p53, Ki67 and GLUT1 expressions

C Xu, X Yang, Y Wang, N Ding, R Han, Y Sun and Y Wang

Cancer Gene Ther 2017 24: 297-303; advance online publication, May 19, 2017; 10.1038/cgt.2017.17

Abstract | Full Text

The novel gene HA117 promotes in vitro and in vivo drug resistance in mouse colon tumor cells

Y X Guo, Y H Xu, G H Zheng and X Q Jin

Cancer Gene Ther 2017 24: 304-308; advance online publication, July 21, 2017; 10.1038/cgt.2017.28

Abstract | Full Text

PTENP1 acts as a ceRNA to regulate PTEN by sponging miR-19b and explores the biological role of PTENP1 in breast cancer

R-K Li, J- Gao, L-H Guo, G-Q Huang and W-H Luo

Cancer Gene Ther 2017 24: 309-315; advance online publication, July 21, 2017; 10.1038/cgt.2017.29

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature